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CD4+ T cells differentiate into multiple effector types,
but it is unclear how they formmemory T cells during
infection in vivo. Profiling virus-specific CD4+ T cells
revealed that effector cells with T helper 1 (Th1) or T
follicular helper (Tfh) cell characteristics differenti-
ated into memory cells, although expression of Tfh
cell markers declined over time. In contrast to
virus-specific effector CD8+ T cells, increased IL-7R
expression was not a reliable marker of CD4+
memory precursor cells. However, decreased Ly6C
and T-bet (Tbx21) expression distinguished a subset
of Th1 cells that displayed greater longevity and
proliferative responses to secondary infection.More-
over, the gene expression profile of Ly6CloT-betint
Th1 effector cells was virtually identical to mature
memory CD4+ T cells, indicating early maturation of
memory CD4+ T cell features in this subset during
acute viral infection. This study provides a framework
for memory CD4+ T cell development after acute viral
infection.
INTRODUCTION
During acute infections, antigen-specific CD8+ and CD4+ T cells
exponentially expand and acquire effector functions to mediate
the clearance of pathogens. After the T cell response peaks,
the majority of effector cells undergo apoptosis, leaving behind
a long-lived population of memory T cells that provides protec-
tion upon reinfection. CD8+ T cells primarily differentiate into
CTLs, whereas CD4+ T cells can differentiate into a multitude
of functionally distinct cell types, such as Th1, Th2, Th17, Tfh,
and Treg cells, depending on the type of infection and inflamma-
tory cytokines produced. Our understanding of the mechanisms
that control effector and regulatory CD4+ T cell differentiation
is much farther advanced than our understanding of how thesecells later form memory T cells. Antigen-specific CD8+ T cell
memory is remarkably stable in most infections, but whether
the same is true for memory CD4+ T cells remains controversial
(Homann et al., 2001; MacLeod et al., 2009; Pepper et al., 2010).
To date, only a handful of signals have been found to be involved
in memory CD4+ T cell development. One critical factor appears
to be TCR avidity, because higher avidity interactions enhance
survival of antigen-specific CD4+ T cells (Fazilleau et al., 2007;
Williams et al., 2008). Additionally, differing strengths of TCR
signaling have also been implicated in the cell fate choices
between Th1, Th2, and Tfh cells (Blander et al., 2000; Fazilleau
et al., 2009; Malherbe et al., 2004). Like CD8+ T cells, persistent
exposure to antigen or MHC molecules does not seem neces-
sary for memory CD4+ T cell homeostasis (Purton et al., 2007;
Swain et al., 1999). Nevertheless, some studies have suggested
that memory CD4+ T cells clonally compete for survival and that
continuous MHC class II interactions favorably affect memory
CD4+ T cell function (De Riva et al., 2007; Hataye et al., 2006;
Polic et al., 2001). Similar to antiviral memory CD8+ T cells,
memory CD4+ T cells also require both IL-7 and IL-15 for their
long-term survival and homeostasis (Kondrack et al., 2003;
Lenz et al., 2004; Li et al., 2003; Purton et al., 2007), but these
signals appear less important during effector CD4+ T cell
contraction (Tripathi et al., 2007, 2010).
The extensive heterogeneity of CD4+ T cells complicates the
study of memory CD4+ T cell formation because the pathways
involved may differ according to each cell type. For instance,
elegant studies of protein immunizations and viral infections
have outlined the formation of heterogenous antigen-specific
CD4+ T cell populations that consist of IFN-g-producing Th1
cells that control viral spread and Tfh cells that migrate to B
cell follicles to stimulate antibody production (Fazilleau et al.,
2007, 2009; Johnston et al., 2009; Roma´n et al., 2002). There-
fore, a more complete understanding of memory CD4+ T cell
development requires that the different cell types be dissected
and their ability to form memory cells examined individually.
Doing so will permit investigation of several unresolved ques-
tions such as the following. Do all types of effector CD4+
T cells generated during infection possess a similar capacity toImmunity 35, 633–646, October 28, 2011 ª2011 Elsevier Inc. 633
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Figure 1. Kinetics of the LCMV-Specific GP66-77 Stg and Polyclonal
CD4+ T Cell Responses
(A) Stg chimeric mice (top) or B6 mice (bottom) were infected with LCMV
Armstrong, and 8, 15, 30, and 60 days p.i., splenocytes were analyzed for
Thy1.1+ or GP66-77 tetramer
+ CD4+ T cells.
(B and C) The number of GP66-77-specific CD4
+ T cells in the spleen (B),
inguinal lymph nodes, liver, lung, and bone marrow (C) was determined at
various time points p.i.
Cumulative numbers of tetramer and Stg TCR transgenic cells from 9–7 mice/
time point frommore than 20 independent experiments are graphed + SD. See
also Figure S1.
Immunity
Antiviral Memory CD4+ T Cell Developmentdifferentiate into memory CD4+ T cells, and if so, can memory
precursor cells be identified within these populations? What
are the genetic pathways and signals utilized to form memory
CD4+ T cells and do these differ among the various CD4+ T cell
populations? Lastly, are functionally distinct memory CD4+
T cell populations stable over time or do they interconvert at
steady state or upon reinfection?
In this study, we sought to distinguish the phenotypically and
functionally distinct virus-specific effector CD4+ T cell subsets
that form during acute lymphocytic choriomeningitis virus
(LCMV) infection and to examine their ability to develop into
memory T cells. Most LCMV-specific effector CD4 T cells differ-
entiated into Th1 and Tfh cells as opposed to Treg-, Th2-, or
Th17-defined cells, and cells expressing Th1 cell phenotypes
populated the memory pool. Cells possessing some, but not
all, Tfh cell traits also persisted in the memory CD4 T cell pool.
The Th1 cell compartment could be divided into Ly6ChiT-bethi
and Ly6CloT-betint T cell subsets, and the Ly6ChiT-bethi T cell
subset produced more IFN-g and granzyme B (GzmB) relative
to the Ly6CloT-betint T cells. T-bet was important for maximal
CD4+ T cell expansion and its heightened expression was neces-
sary for formation of Ly6Chi Th1 effector cells. Unlike effector
CD8+ T cells, increased IL-7 receptor alpha (IL-7R) expression
did not mark memory precursor CD4+ T cells because the
IL-7Rlo T cells converted to IL-7Rhi T cells rapidly after viral clear-
ance, and both effector cell subsets gave rise to memory T cells
similarly. However, the Ly6CloT-betint Th1 cells had an enhanced
ability to persist and proliferate in response to secondary infec-
tion compared to the Ly6ChiT-bethi T cells. The Ly6CloT-betint
memory CD4+ T cells also contained CD62LhiCCR7hi central
memory T (Tcm) cells. Importantly, the Ly6CloT-betint effector
CD4+ T cells had a transcriptional signature that was strikingly
similar to mature memory CD4+ T cells, indicating that these
effector cells attained memory cell features rapidly after infec-
tion. Cumulatively, this work provides a molecular and pheno-
typic foundation for the development of memory Th1 and Tfh
cells during a viral infection and identifies phenotypically and
functionally distinct subpopulations of virus-specific memory
CD4+ T cells that may play different protective roles in long-
term immunity to viruses.
RESULTS
Increased IL-7R Expression Does Not Mark Memory
Precursor Effector CD4+ T Cells
To begin to study virus-specific memory CD4+ T cells, we first
outlined the kinetics of the virus-specific CD4+ T cell response
during acute LCMV infection using both GP66-77 MHC class II
tetramer staining and TCR transgenic Smarta (Stg) CD4+
T cells that recognize the GP66-77 epitope of LCMV. The
Stg CD4+ T cell response largely reflected the endogenous
GP66-77-specific CD4
+ T cell response in terms of cell number,
function, and phenotype (Figure 1A; see Figures S1A and S1B
available online). A potential consideration was that GP66-77
MHC class II tetramer staining required a 2 hr incubation at
37C, during which T cells can be activated and certain attributes
may be affected (Figure S1B). Therefore, the cross validation of
results between the two experimental systems is important for
drawing conclusions and was done throughout this study. The634 Immunity 35, 633–646, October 28, 2011 ª2011 Elsevier Inc.Stg and polyclonal GP66-77-specific CD4
+ T cell response
peaked at day 8 postinfection (p.i.) and declined (103 over
60 days) thereafter, leaving a detectable population of memory
CD4+ T cells that was maintained over the time of analysis
(150 days) (Figure 1). Furthermore, LCMV-specific CD4+
T cells were predominantly found in the spleen but could also
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and S1D).
Amajor aimof this studywas to distinguish the antiviral effector
CD4+ T cells that had the greatest ability to persist and populate
the memory CD4+ T cell pool. Increased IL-7R expression is
a key trait in virus-specific effector CD8+ T cells that helps to
distinguish memory precursor cells in some infections (Kaech
et al., 2003). The kinetics of IL-7R expression in antiviral CD4+
T cells was similar to that seen inCD8+ T cells; that is, themajority
of LCMV-specific effector CD4+ T cells at day 8 p.i. were IL-7Rlo,
but20%of the cells were IL-7Rhi (Figures 2A and 2B). Over time
as the pool of memory CD4+ T cells formed, the frequency of
IL-7Rhi T cells increased to comprise more than 90% of the
cells (Figures 2A and 2B; Purton et al., 2007). This expression
pattern suggested that, like in CD8+ T cells, increased IL-7R
expression in CD4+ T cells might also serve as a marker for
memory precursor cells. To examine this hypothesis, we first
compared whether any of the phenotypes previously found to
differ between IL-7RhiCD8+ and IL-7RloCD8+ T cells, such as
expression of T-bet, Bcl-2, and IL-2, were also observed in the
CD4+ T cell subsets (Joshi et al., 2007; Kaech et al., 2003).
However, unlike CD8+ T cells, the expression of these proteins,
and others such as GzmB and IFN-g, were nearly identical
between the IL-7Rhi and IL-7Rlo effector CD4+ T cells (Figure 2C).
To evaluate directly whether increased IL-7R expression
indelibly ‘‘marked’’ effector CD4+ T cells with greater survival
and memory cell potential, we sorted day 8 IL-7Rhi and IL-7Rlo
Stg CD4+ T cells and adoptively transferred them into infec-
tion-matched congenic recipient mice that were sequentially
bled over the next 10 days. This experiment showed that
nearly all donor IL-7Rhi T cells remained IL-7Rhi, but surprisingly,
most of the donor IL-7Rlo T cells converted into IL-7Rhi T cells
(Figures 2D and 2E). Therefore, in contrast to antiviral CD8+
T cells, IL-7R was not stably repressed in antiviral CD4+
T cells, and IL-7Rhi memory CD4+ T cells arose in part from
conversion of IL-7Rlo to IL-7Rhi effector T cells. In addition, the
absolute number of donor CD4+ T cells recovered after
10 days was nearly identical between the two groups (Figure 2F),
and when the recipient mice were infected with LCMV, the
secondary expansion of IL-7Rhi and IL-7Rlo donor CD4+ T cells
was quite similar (Figure 2G). Therefore, the survival and
secondary proliferative responses of the IL-7Rhi and IL-7Rlo
donor CD4+ T cell populations were comparable. Together,
these data show that IL-7R repression is transient in effector
CD4+ T cells and is not indicative of cells with shortened lifespan
or reduced memory cell potential.
Characterization of Virus-Specific Th1- and
Tfh-Containing CD4+ Cell Subsets
Because early differences in IL-7R expression did not help to
demarcate effector CD4+ T cells that displayed enhanced
survival and memory cell properties, we then investigated
whether expression of other relevant T cell markers may distin-
guish such cells. Our past work on CD8+ T cells identified that
T-bet acted as a rheostat in controlling effector CD8+ T cell differ-
entiation. Increased levels of T-bet promoted development of
terminal effector CD8+ T cells whereas reduced T-bet expression
promoted development of long-lived memory precursor cells
(Joshi et al., 2007). Therefore, we investigated whether T-betexpression may similarly distinguish subsets of effector CD4+
T cells with distinct properties and long-term fates. Although
decreased IL-7R expression failed to correlate with increased
T-bet expression in effector CD4+ T cells (Figure 2C), we found
that another receptor regulated by T-bet, Ly6C (Matsuda et al.,
2006), could discriminate effector and memory CD4+ T cells
that express different amounts of T-bet. Ly6Chi effector CD4+
T cells expressed more T-bet than did Ly6Clo T cells. Interest-
ingly, when Ly6C expression was paired with P-selectin ligand
1 (PSGL1) expression, a receptor that is decreased on Tfh cells
(Odegard et al., 2008; Poholek et al., 2010), three distinct
subsets of virus-specific CD4+ T cells could be distinguished in
direct association with T-bet expression: (1) PSGL1hiLy6Chi
T-bethi Th1 cells, (2) PSGL1hiLy6CloT-betint Th1 cells, and (3)
PSGL1loLy6CloT-betlo Tfh cells (Figures 3A and S2A). At day 8
p.i, the majority (50%) of GP66-77-specific CD4+ T cells were
PSGL1hiLy6Chi Th1 effector cells that expressed the highest
amounts of T-bet, IFN-g, and GzmB. The second most prevalent
subset (30%) was the PSGL1hiLy6Clo T effector cells, which
also contained Th1 cells, but relative to the PSGL1hiLy6Chi
T cells, expressed intermediate amounts of T-bet and produced
modestly less IFN-g and GzmB. Both PSGL1hiLy6Chi and
PSGL1hiLy6Clo T cells expressed similar amounts of IL-2,
IL-7R, CD122 (IL-2Rb), and CD27. The third and smallest
fraction of the effector cell population (20%) was the PSGL1lo
Ly6Clo T cell subset that contained mostly Tfh cells because
they expressed the highest amounts of canonical Tfh cell
markers ICOS, CD200, CXCR5, and PD-1 (Figures 3A and
S2A). The PSGL1loCD4+ T cells also expressed the Tfh cell
lineage TF Bcl6 (Figure S2C) and lower amounts of CD27.
Interestingly, a substantial portion of the LCMV-specific CD4+
T cells (between 30% and 40% of the cells) did not produce
IFN-g or other trademark Th cell lineage factors including
FoxP3 or IL-17, suggesting the existence of additional func-
tioning or less differentiated effector CD4+ T cells (Figures S2D
and S2E and data not shown).
Further, we analyzed frozen splenic sections from day 8
LCMV-infected mice by immunofluorescence microscopy to
ascertain the location of the CD4+ T cell subsets. Nearly all of
the Stg CD4+ T cells sequestered in the B cell follicles were
PSGL1lo and Ly6Clo whereas the PSGL1hiLy6CloCD4+ T cells
were mainly in the T cell zones and the PSGL1hiLy6Chi T cells
localized predominantly to the red pulp (Figures S2F and S2H).
Thus, each of these phenotypically and functionally distinct
effector subsets occupied discrete anatomical locations in the
spleen during a viral infection. Altogether, this analysis showed
that at the peak of an acute viral infection, at least three pheno-
typically, anatomically, and functionally distinct subsets of
LCMV-specific effector CD4+ T cells can be identified that vary
according to the amount of T-bet expressed.
Tracking the Formation of Th1 and Tfh Memory
CD4+ Cells
Next, we followed the different antiviral CD4+ T cell subsets over
several months after infection to examine memory cell formation
in the spleen, inguinal LN, liver, lung, and BM. GP66-77-specific
memory CD4+ T cells were found in all tissues examined, but
the PSGL1loCD4+ T cells were found predominantly in the
spleen and LNs (Figure S1C). For the most part, the frequenciesImmunity 35, 633–646, October 28, 2011 ª2011 Elsevier Inc. 635
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Figure 2. IL-7R Expression Does Not Mark Memory Precursor Effector CD4+ T Cells
(A and B) Frequency of IL-7R on virus-specific CD4+ T cells was determined at various time points p.i. and shown in histogram plots (A) and in line graph ± SD (B).
(C) Expression of the indicated proteins was compared between IL-7Rhi (black line) and IL-7Rlo (gray shaded) Stg CD4+ T cells at day 8 p.i. and shown in
overlapping histograms.
(D–F) IL-7Rhi (black) and IL-7Rlo (gray) Stg CD4+ T cells were purified by FACS 8 days p.i. and equal numbers were transferred into infection-matched congenic
recipients. Donor cells in the blood were analyzed for IL-7R expression over 10 days posttransfer and the frequency of IL-7Rhi donor T cells are shown in
representative FACS plots (D) or cumulative line graph ± SD (E).
(F) Bar graph shows the absolute number of donor cells + SD recovered 10 days posttransfer.
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remained fairly consistent; however, there was a noticeable,
but insignificant, change in ratio of PSGL1hiLy6Chi and PSGL1hi
Ly6Clo T cells over time (Figures 3C and 3D). At day 8 the Ly6Chi
T cells represented 60% of the PSGL1hi T cell subset, but
several months later the Ly6Chi T cells comprised a smaller frac-
tion (40%) of the population (Figures 3C and 3D). The decline in
PSGL1hiLy6Chi T cells between days 8 and 30 p.i. was evenmore
apparent in the polyclonal CD44hiCD4+ T cell population (Fig-
ure 3C, right bar graph).
Next, the phenotypes and functions of thememory CD4+ T cell
subsets were examined and, most notably, the hierarchy of
T-bet expression was maintained in the three subsets. The
PSGL1hiLy6ChiT-bethi memory T cells also expressed more
IFN-g and CD122 than their PSLG1hiLy6CloT-betint counterparts.
GzmB expression declined rapidly after viral clearance and
was not expressed by any of the virus-specific memory CD4+
T cells, and they also expressed similar amounts of IL-7R and
CD27 (Figures 3B and S2B). Another noteworthy observation
was that in contrast to the phenotypes observed at day 8 p.i,
the memory PSGL1loLy6CloCD4+ T cells did not retain high
expression of the Tfh cell markers ICOS, CD200, CXCR5, and
PD-1 at later time points (compare Figures 3A and 3B). However,
the PSGL1hiLy6Clo and PSGL1loLy6Clo T cells maintained
slightly higher expression of CXCR5 and ICOS relative to the
PSGL1hiLy6Chi memory T cells. This general reduction in Tfh cell
marker expression correlates with the decline in germinal center
reactions between 15 and 30 days p.i. and is similar to that previ-
ously reported (MacLeod et al., 2011). The PSLG1loLy6Clo T cells
also maintained lower expression of IFN-g, IL-2, CD122, and
CD27 but expressed similar amounts of IL-7R compared to
the PGSL1hi memory T cell subsets. Immunofluorescent micro-
scopy of splenic sections from day 30 p.i. revealed that
PSGL1+ T cells remained excluded from B cell follicles after
resolution of infection, and the majority of LCMV-specific
memory CD4+ T cells were located in the T cell zone and the
red pulp (Figure S2G).
Lastly, we analyzed the generation of virus-specific memory
CD4+ T cells with Tem and Tcm cell traits. Similar to LCMV-
specific CD8+ T cells, CD62L and CCR7 expression is greatly
repressed on the virus-specific effector CD4+ T cells early during
infection, but over time CD62L+CCR7+ Tcm cells gradually
emerged in the memory CD4+ T cell population (Figure 3E).
Interestingly, when combined with Ly6C, we found that the
CD62L+CCR7+ Tcm cells were preferentially, but not exclu-
sively, enriched in the Ly6Clo memory T cell compartment
compared to the Ly6Chi T cell compartment. Collectively, these
data show that after acute LCMV infection, the memory CD4+
T cell population is heterogeneous and functionally diverse.
IFN-g-producing Th1 memory CD4+ cells persist, but there is
a general reduction of Tfh cell-associated markers in the resting
memory CD4+ T cell pool. Over time, the PSGL1hiLy6Clo memory
CD4+ T cell population becomes the dominant subset and
contains Tcm cells.(G) As in (D) above, except the donor IL-7Rhi and IL-7Rlo effector T cells were parke
LCMV. Seven days after secondary infection, the number of donor Stg CD4+ T c
Data are cumulative of three independent experiments. NS, not statistically signT-bet-Dependent Regulation of Virus-Specific Effector
CD4+ T Cell Subsets
To better understand the factors that control the development of
these functionally diverse effector CD4+ T cell subsets, we inter-
rogated the role of T-bet because it was expressed in a graded
manner in the three virus-specific CD4+ T cell subsets.We exam-
ined the effect of removing one or two copies of Tbx21 on the
types of virus-specific CD4+ T cells that form by generating an
allelic series of Tbx21+/+, Tbx21+/, and Tbx21/ Stg TCR trans-
genic mice to use as donor cells for chimeras. Eight days after
LCMV infection, the functional and phenotypic characteristics
of the Stg CD4+ T cells were analyzed. As expected given its
role in Th1 cell lineage commitment, we observed a dose-depen-
dent reduction in the percentage of IFN-g-producing Th1 cells in
the Tbx21+/ and Tbx21/ Stg CD4+ T cells (data not shown).
Additionally, similar to LCMV-specific CD8+ T cells, we saw
a strong requirement for T-bet for maximal clonal expansion of
virus-specific CD4+ T cells (Figure 4; Joshi et al., 2007). Most
notably, we examined the types of effector CD4+ T cells that
formed and found that the frequency of PSGL1hiLy6Chi T cells
directly correlated with Tbx21 gene copy number. Removal of
one (Tbx21+/) or two (Tbx21/) copies of the gene encoding
T-bet decreased the proportion of PSGL1hiLy6Chi effector
CD4+ T cells that formed by30% and50%, respectively (Fig-
ure 4). Likewise, there was dose-dependent compensatory
increase in the fraction of PSGL1hiLy6Clo and PSGL1loLy6Clo
effector CD4+ T cells. Thus, T-bet deficiency most overtly
affected the formation of PSGL1hiLy6Chi Th1 cells, in accor-
dance with its increased abundance in this subset. These results
demonstrate that T-bet acts in a graded manner to generate
functionally diverse effector CD4+ T cell subsets during viral
infection.
PSGL1hiLy6CloCD4+ T Cells Display Enhanced Survival
and Proliferative Responses to Reinfection
The above comparisons revealed several interesting parallels
between CD4+ and CD8+ effector and memory T cell differentia-
tion during LCMV infection. For instance, KLRG1loIL-7Rhi
memory precursor CD8+ T cells (1) express less T-bet, (2) prefer-
entially localize to the T cell zone, (3) have greater longevity, (4)
give rise to self-renewing Tcm cells at resting states, and (5)
mount stronger proliferative responses after secondary infection
than KLRG1hiIL-7Rlo short-lived effector T cells (Joshi et al.,
2007; Jung et al., 2010; Kaech et al., 2003). Likewise, the
PSGL1hiLy6CloCD4+ T cells similarly expressed less T-bet, pref-
erentially localized to the T cell zone, contained Tcm cells, and
constituted a greater proportion of the memory CD4+ T cell pop-
ulation. Therefore, we hypothesized that the PSGL1hiLy6Clo
T cell subset may contain less differentiated Th1 cells with addi-
tional memory cell features.
To investigate this point more closely, we compared two
cardinal memory T cell properties between the PSGL1hiLy6Chi
and PSGL1hiLy6Clo effector CD4+ T cell subsets: enhanced sur-
vival during the contraction phase and proliferative responses tod for 30 days in naive congenic recipients that were subsequently infected with
ells in the spleen + SD was measured.
ificant.
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Figure 3. Formation of Distinct LCMV-Specific Effector CD4+ T Cells Subsets
(A and B) Stg chimeric mice were infected with LCMV and 8 (A) or 30 (B) days p.i. splenocytes were analyzed by flow cytometry for expression of the indicated
proteins. PSGL1hiLy6Chi (red), PSGL1hiLy6Clo (blue), and PSGL1loLy6Clo (green) Stg CD4+ T cells were gated and the average MFI + SD for the various proteins
are shown in bar graphs. CD4+ T cells were also stimulated with GP61-80 peptide in vitro and the average frequency of IFN-g
+ and IL-2+ Stg T cells + SD are shown.
Data shown are representative of three independent experiments (n = 3 per group).
(C) Stacked bar graph of Stg CD4 T cells (left) or CD44hi polyclonal CD4+ T cells (right)  SD in each subset after LCMV infection.
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Figure 4. T-bet-Dependent Formation of Antiviral CD4+ T Cell Subsets
1 3 104 Tbx21+/+, Tbx21+/, or Tbx21/ Stg CD4+ T cells were adoptively transferred into three groups of mice and then infected with LCMV Armstrong. Eight
days p.i. the frequency of Stg cells and expression of PSGL1 and Ly6C was analyzed. Representative examples in FACS plots (A) and cumulative numbers of
donor Stg CD4+ T cells + SD (B) and frequencies  SD of the different effector CD4+ T cell subsets from three independent experiments. *p < 0.05.
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differences in the ability of the effector subsets to persist after
viral clearance, we purified PSGL1hiLy6Chi and PSGL1hiLy6Clo
Stg effector CD4+ T cells at day 8 p.i. and transferred equal
cell numbers into separate groups of uninfected congenically
marked recipient mice. After 7–10 days, we observed that
a substantially larger number of Ly6Clo donor T cells were recov-
ered in the spleen and other tissues relative to the Ly6Chi
donor T cells (Figure 5A and data not shown), indicating
that the Ly6Clo effector CD4+ T cells were preferentially main-
tained during the contraction phase relative to their Ly6Chi
T cell counterparts. We then examined the phenotypic stability
of the donor cells and found that most Ly6Chi donor T cells
remained Ly6Chi, but50% of the Ly6Clo T cells became Ly6Chi
after transfer (Figure 5A, right). Further, the hierarchy of T-bet
expression was dictated by the current phenotype of the cells
and not the donor phenotype; that is, Ly6Clo donor T cells
that converted to Ly6Chi T cells expressed more T-bet than
Ly6Clo T cells that maintained their Ly6Clo phenotype (data not
shown). Together, these observations demonstrate that the
Ly6Chi effector CD4+ T cells did not persist as well as the
Ly6Clo T cells and suggest that increased Ly6C expression
may be a terminal phenotypic marker of Th1 CD4+ cells. That
Ly6CloT-betint T cells converted to Ly6ChiT-bethi T cells after
transfer, in the absence of further antigenic stimulation, also
suggested an interesting model of memory CD4+ T cell homeo-(D) Total number of Stg CD4+ T cells + SD of each subset during LCMV infection
experiments are graphed.
(E) The expression of CD62L and CCR7 on Ly6Chi and Ly6Clo Stg CD4+ T cells a
See also Figure S2.stasis whereby the Ly6CloCD4+ T cells steadily repopulate and
sustain the pool of Ly6Chi Tem memory CD4+ cells. This model
helps to explain the existence of Ly6ChiCD4+ T cells at all time
points examined (Figure 3C). Therefore, the greatest ability to
survive the contraction phase and the plasticity to further differ-
entiate into terminal Th1 effector cells resides within the effector
Ly6CloCD4+ T cell population.
Next, we compared the ability of the PSGL1hiLy6Chi and
PSGL1hiLy6Clo memory CD4+ T cells isolated from days 30–60
after LCMV infection to respond to a secondary infection by
transferring equal numbers of donor Stg CD4+ T cells from
each subset and infecting the recipient mice 1 day later with
LCMV clone 13. These experiments showed that the memory
Ly6Clo T cells possessed a greater ability to undergo secondary
proliferation compared to the Ly6Chi T cells (Figure 5B). As
expected based on a linear model of differentiation, after
secondary infection the majority of the donor Ly6ChiCD4+
T cells remained Ly6Chi, whereas more than half of the Ly6Clo
T cells became Ly6Chi secondary effector T cells (Figure 5B,
right). When these experiments were repeated with donor
PSGL1hiLy6Chi and PSGL1hiLy6Clo effector CD4+ T cells from
day 8 p.i., nearly identical results to the donor memory T cells
were observed. That is, the day 8 Ly6Clo effector CD4+ T cells
also displayed a more robust secondary burst than the Ly6Chi
donor T cells and many cells upregulated Ly6C expression (Fig-
ure 5C). Collectively, this series of experiments demonstrated. Cumulative data from 9–37 mice/time point from more than 20 independent
t day 60 p.i. is shown in FACS plots.
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Figure 5. Enhanced Memory Cell Properties in PSGL1hiLy6Clo Effector CD4+ T Cells
(A) PSGL1hiLy6Chi or PSGL1hiLy6Clo Stg CD4+ T cells were purified 8 days p.i. and adoptively transferred at equal numbers (1.5 3 106) into naive congenic
recipients. 7–10 days later, the number of donor Stg CD4+ T cells remaining in the spleen and their phenotypes SD were determined. Cumulative data from six
independent experiments is shown; black line represents the mean.
(B and C) 5 3 105 PSGL1hiLy6Chi or PSGL1hiLy6Clo Stg CD4+ T cells were purified 30–60 (B) or 8 (C) days p.i. and transferred into mice that were subsequently
infected with LCMV clone 13. Six days later, the numbers of splenic donor Stg CD4+ T cells and their phenotypes were determined  SD. Cumulative data from
three (B) or five (C) independent experiments are shown. *p < 0.05.
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the contraction phase and the ability to robustly proliferate
upon secondary infection) were enhanced in virus-specific
Ly6CloCD4+ T cells. These traits were evident as early as day 8
p.i., suggesting that the PSGL1hiLy6ChiT-bethi T cell subset
contained more terminally differentiated Th1 cells whereas the
PSGL1hiLy6CloT-betint T cell subset contained less differentiated
Th1 cells that displayed a greater capacity to persist and
respond to secondary infection.
Transcriptional Profile of PSGL1hiLy6Clo Effector CD4+
T Cells Resembles Memory CD4+ T Cells
To further characterize the effector subsets and identify genetic
pathways and transcription factors involved in their differentia-
tion, we performed genome-wide gene expression profiling of
the three day 8 effector cell populations: (1) PSGL1hiLy6Chi, (2)
PSGL1hiLy6Clo, and (3) PSGL1loLy6Clo, along with (4) day 60
memory PSGL1hi and (5) naive Stg CD4+ T cells via Illumina
BeadChips. Results of this microarray confirmed the validity of
our phenotyping by flow cytometry in many ways and showed
distinct gene signatures for the three effector subsets. For
example, the PSGL1loLy6Clo T cell subset showed increased
expression of Tfh cell signature genes such as Cxcr5, Pdcd1
(PD1), Il21 (IL-21), and Bcl6 (Figure 6A, green asterisks; Table
S1). The PSGL1hiLy6Chi effector CD4+ T cells were more Th1
cell-like with increased expression of Tbx21, Ifng, and Cxcr3
(Figure 6A, red asterisks; Table S1). The PSGL1hiLy6Clo effector
CD4+ T cells also displayed increased expression of Th1 cell
genes, but these were expressed at relatively lower levels than
their Ly6Chi T cell counterparts (Figure 6A; Table S1).
Clustering analysis was performed on signature gene sets
containing genes differentially expressed by at least 32-fold in
any one group relative to naive Stg CD4+ T cells, and a heatmap
of these expression values was generated. This analysis re-
vealed an unexpected finding in that the day 8 PSGL1hiLy6Clo
T cells clustered more closely with day 60 memory cells than
their day 8 PSGL1hiLy6Chi effector CD4+ T cell counterparts (Fig-
ure 6A). The same relationship was also found when considering
a 2-fold cutoff or when considering the set of most variable
genes across the samples (CV > 0.5) (data not shown). We
also performed a pair-wise comparison of the differentially ex-
pressed genes between all the different groups relative to naive
CD4+ T cells (greater than 2-fold change and q < 0.05), and this
again revealed a striking correlation (r = 0.95) in the gene expres-
sion patterns between day 8 PSGL1hiLy6Clo effector T cells and
day 60 PSGL1hi memory CD4+ T cells (Figure 6B). Similarity in
gene expression between the two day 8 PSGL1hiLy6Clo and
PSGL1hiLy6Chi effector T cell populations was also evident (r =
0.85) but considerably less than the day 60 memory CD4+
T cells, and less similarity in gene expression was observed
between day 60 PSGL1hi memory T cells and either day 8
PSGL1hiLy6Chi (r = 0.78) or PSGL1loLy6Clo (r = 0.78) effector
T cells. Thus, even by day 8 p.i., the PSGL1hiLy6Clo T cells dis-
played a gene expression profile that was nearly identical to
maturememoryCD4+ T cells. These data suggest that the Ly6Clo
effector T cells started to acquire memory CD4+ T cell qualities
early after infection, which may be akin to the rapid transition
of effector CD4+ T cells to mature memory cells after removal
of antigen previously reported (McKinstry et al., 2007).Finally, we directly compared the gene expression profiles of
PSGL1hiLy6Chi and PSGL1hiLy6Clo effector Th1 CD4+ cells.
Surprisingly, this revealed the presence of several Treg cell-
associated genes such as Foxp3, Cd83, Nt5e (CD73), Itgae
(CD103), and Folr4 in the Ly6Clo T cell subset, despite not
detecting FoxP3+ GP66-77-specific CD4
+ T cells by intracellular
staining (Table 1; Figure S2D). Other notable differences
between these Ly6Chi and Ly6Clo T cell subsets were receptors
involved in migration and adhesion such as Ccr7, Cx3cr1, Ccr6,
Sell (CD62L), the integrins Itgae (CD103) and Itgad (CD11d), and
potential survival factors Il6ra, Serpina3g (Spi2a), and Igf1r. For
additional details on the differentially expressed genes across
the different cell populations including transcription factors,
cytokines, chemokines, and cytokine/chemokine receptors,
refer to Table S2. In summary, these data identify numerous
candidate genes that could contribute to differential functions
and fates of the distinct effector CD4+ T cell subsets and the
enhanced memory cell potential of Ly6Clo effector T cells.
DISCUSSION
Despite the indispensable role of CD4+ T cells in the preservation
of long-term immunity to pathogens, the factors regulating the
survival of effector CD4+ T cells and their transition to memory
CD4+ T cells are largely unknown. Because CD4+ T cells can
differentiate into numerous functionally distinct populations of
helper T cells during infection, it is imperative that one first
dissects and examines memory cell formation in each effector
cell subset individually to gain a clearer understanding of
memory CD4+ T cell development. In this study we performed
a comprehensive phenotypic, functional, and genomic profiling
of LCMV-specific CD4+ T cells during their effector to memory
transition. Our study revealed that during LCMV infection,
virus-specific CD4+ T cells differentiated into Th1 and Tfh
effector cells that could be distinguished by differential expres-
sion of PSGL1 and Ly6C. Cells containing Th1 and Tfh cell
features were present in the resting memory pool, but interest-
ingly, most markers commonly used to define Tfh cells (such
as increased expression of PD1, CXCR5, ICOS, and CD200)
decreased over time on the PSGL1lo memory CD4+ T cells.
Two major subsets of antiviral Th1 cells could be distinguished
based on expression of Ly6C, a GPI-anchored membrane
glycoprotein with poorly defined function that can act as a costi-
mulatory molecule for T cells (Bamezai, 2004). We propose that
the Ly6Chi effector CD4+ T cells represent more terminally differ-
entiated Th1 cells because they expressed greater amounts of
T-bet, CD122, IFN-g, and GzmB and had increased rates of
contraction and reduced proliferative responses relative to the
Ly6Clo T cells. Furthermore, the Ly6Clo Th1 effector cells dis-
played a gene expression profile strikingly similar to that of
mature memory CD4+ T cells and contained Tcm cells. It will
be important in the future to examine how these phenotypically
and functionally distinct Th1 cell subsets vary across different
types of infections and immunizations, especially in cases where
CD4+ T cell memory decays over time.
This study identifies several interesting differences and paral-
lels with memory CD8+ T cell development. Increased IL-7R
expression identifies effector CD8+ T cells (IL-7Rhi CTLs) with
increased memory cell potential (Kaech et al., 2003). Based onImmunity 35, 633–646, October 28, 2011 ª2011 Elsevier Inc. 641
Figure 6. Gene Expression Profiles of PSGL1hiLy6Clo Effector CD4+ T Cells and Memory CD4+ T Cells Are Highly Similar
Three independent Stg CD4+ T cell samples containing naive, day 8 PSGL1loLy6Clo, day 8 PSGL1hiLy6Chi, day 8 PSGL1hiLy6Clo, or day 60 PSGL1hi memory CD4+
T cells were purified by FACS, and whole-genome mRNA expression profiles were characterized with Illumina microarrays. See also Table S1.
(A) Clustering analysis and heatmap of expression values showing the log2 transformed expression intensity of any gene with a 32-fold change or higher over
naive (q < 0.0001). Genes marked by an asterisk are mentioned in the Results or Discussion.
(B) The overall similarity in gene expression between the different effector andmemory CD4+ T cell samples was examined, in a pairwisemanner, by identifying all
the genes that were differentially expressed in any sample relative to naive CD4+ T cells (greater than 2-fold change and q < 0.05) and then plotting their relative
intensities in each respective sample compared to the naive population.
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Table 1. Differentially Expressed Genes in PSGL1hiLy6Chi
Compared to PSGL1hiLy6Clo Effector CD4+ T Cell Subsets
PSGL1hiLy6Chi
Compared to
PSGL1hiLy6Clo
PSGL1hiLy6Chi
Compared
to Naive
PSGL1hiLy6Clo
Compared
to Naive
Ly6c1 78.19 4.80 15.26
Cx3cr1 8.70 22.95 2.64
Itgad 7.08 18.35 2.59
Il18rap 5.38 23.31 4.34
Gzmm 4.79 8.74 1.77
Irak3 4.36 7.93 1.82
Ifng 4.36 95.63 24.03
Ccr5 3.72 18.70 5.03
Tbx21 3.14 58.36 18.62
Il12rb2 2.67 3.45 1.29
Il21 1.49 4.30 6.39
Bcl6 1.74 1.10 1.59
Cd200 1.99 1.43 1.40
Il2 2.62 2.30 6.03
Serpina3f 3.46 3.97 13.12
Ccr7 3.88 12.96 3.34
Cxcr5 4.31 3.25 13.59
Il4 6.43 1.08 5.93
Il6ra 6.84 10.85 1.59
Serpina3g 7.72 4.44 34.24
Ccr6 8.03 2.56 20.55
Igf1r 9.14 3.81 2.40
Folr4 10.06 5.70 1.59
Cd81 13.00 3.10 4.19
Sell 10.82 7.84 1.38
Nt5e 11.85 67.43 5.69
Cd83 14.15 1.58 8.96
Itgae 14.46 1.17 16.87
Nrn1 18.36 1.87 9.80
Foxp3 29.56 4.37 4.87
A selective list of differentially expressed genes between PSGL1hiLy6Chi
and PSGL1hiLy6Clo effector CD4+ T cell subsets based on fold change
as determined with GeneSpring GX11. The fold change values of
PSGL1hiLy6Chi compared to PSGL1hiLy6Clo (left), PSGL1hiLy6Chi com-
pared to naive (middle), and PSGL1hiLy6Clo compared to naive (right)
are shown. See also Table S2.
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CD4+ and CD8+ T cells, we predicted that differential IL-7R
expression might also distinguish short- and long-lived effector
CD4+ T cells. However, a different scenario was revealed in
which the IL-7R repression was transient in CD4+ T cells and
the IL-7Rlo effector T cells converted to IL-7Rhi cells. Both
IL-7RhiCD4+ and IL-7RloCD4+ T cells showed an equal ability
to survive and populate the memory CD4+ T cell pool and had
comparable responses to secondary infection. Thus, decreased
IL-7R expression was not a defining feature of short-lived
effector CD4+ T cells. The difference in the stability of IL-7R
repression between effector CD4+ and CD8+ T cells may be
due to variations in the transcriptional repressor Gfi-1 that canrepress Il7ra transcription in CD8+ but not in CD4+ T cells (Chan-
dele et al., 2008; Park et al., 2004). However, despite this impor-
tant difference between virus-specific CD4+ and CD8+ T cells,
this study revealed other noteworthy conceptual and functional
similarities between Ly6CloCD4+ Th1 cells and IL-7RhiCD8+
CTL. For instance, with respect to the Ly6Chi Th1 and IL-7Rlo
CTL cells, the Ly6Clo Th1 and IL-7Rhi CTL cells displayed
enhanced survival during the contraction phase and greater
proliferative responses to secondary infection. The Ly6Clo Th1
cells and IL-7Rhi CTL also preferentially resided in the T cell
zone whereas the Ly6Chi Th1 cells and IL-7Rlo CTL predomi-
nantly localized to the red pulp in the spleen. Additionally, both
the Ly6Clo memory CD4+ T cell and IL-7RhiCD8+ T cell popula-
tions contained a greater frequency of CD62L+CCR7+ Tcm cells
compared to the Ly6ChiCD4+ and IL-7RloCD8+ T cells (Kaech
et al., 2003).
Lastly, the graded expression of T-bet was observed in both
effector CD4+ and CD8+ T cell subsets with the Ly6Chi Th1 cells
and IL-7Rlo CTL expressing higher amounts of T-bet compared
to the Ly6Clo Th1 cells and IL-7Rhi CTL. In both T cell types,
elevated amounts of T-bet were required for maximal clonal
expansion and formation of terminal PSGL1hiLy6Chi Th1 cells
and IL-7Rlo CTL, and likewise, reducing T-bet by one or two
copies proportionally increased the frequency of PSGL1hiLy6Clo
Th1 cells and IL-7Rhi CTL (Joshi et al., 2007). Thus, T-bet acts in
a dose-dependent manner in both CD4+ and CD8+ T cells to
generate distinct effector cell subpopulations, and we propose
that, analogous to CD8+ T cells, T-bet may act like a rheostat
during Th1 cell differentiation to balance terminal effector cell
differentiation and memory cell potential. Additionally, one may
consider the Ly6Clo Th1 cells and IL-7Rhi CTL to be more plastic
or multipotent because these cells can develop into Ly6Chi
T-bethi Th1 cells and IL-7RloT-bethi CTL, respectively, upon re-
stimulation whereas the converse was not as evident. These
data suggest a linear model of effector differentiation common
to CD4+ and CD8+ T cells wherein ‘‘less differentiated’’ T-betint
effector cells can form and persist or further differentiate into
terminal T-bethi effector cells with robust effector function but
reduced memory cell potential. Identifying the signals that direct
the development of Ly6ChiT-bethi and Ly6CloT-betint Th1 cells
and whether Ly6C itself is involved in this process will be impor-
tant to address in the future.
In agreement with previous work (Harrington et al., 2008;
Pepper et al., 2010), our data showed that LCMV-specific Th1
cells efficiently entered the memory pool. However, our work
also showed that not all Th1 cells have an equal potential to do
so because the PSGL1hiLy6CloT-betint effector CD4+ T cells
showed greater rates of persistence and accumulation in the
memory cell pool after infection. Our gene expression profiling
between PSGL1hiLy6Chi and PSGL1hiLy6Clo effector T cells
identified several differentially expressed candidate genes that
could potentially increase the lifespan of PSGL1hiLy6Clo T cells
such as Serping3a (Spi2a), Il6ra, and Igf1r. Interestingly, Spi2a
is also elevated in CD8+ memory precursor cells and is neces-
sary formemory CD8+ T cell formation (Liu et al., 2004). Nonethe-
less, at all time points examined, 30%–40% of the memory
CD4+ T cell population contained PSGL1hiLy6Chi T cells. Inter-
estingly, the results of our adoptive transfer experiments showed
that interconversion between the subsets was occurring evenImmunity 35, 633–646, October 28, 2011 ª2011 Elsevier Inc. 643
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Ly6Clo to Ly6Chi Th1 cells was greatest, suggesting that the
Ly6Chi memory CD4+ T cell compartment is homeostatically
replenished from Ly6Clo memory T cells. It is currently unclear
what drives Ly6Clo/ Ly6Chi CD4+ T cell conversion in the
absence of antigen, but one candidate is type I IFNs because
these can induce Ly6C expression in T cells (Khan et al., 1990).
Therefore, bystander exposure to inflammatory cytokines may
impact CD4+ memory T cell phenotype, function, and homeo-
stasis. On this note, another report also showed that memory
CD4+ T cells generated by a noninfectious immunization
(peptide + LPS) preferentially reside in the BM and express
Ly6C (Tokoyoda et al., 2009); however, our study on viral infec-
tion and that previously on bacterial infection (Pepper et al.,
2010) did not reveal a similar tissue tropism. LCMV-specific
CD4+ T cells did reside in the BM, but the frequency and number
was less than that observed in the spleen and liver and compa-
rable to that in LN and lung.
Our data also show that LCMV-specific PSGL1loLy6CloCD4+
T cells were present at memory time points, even after germinal
center responses had ceased, but these PSGL1loLy6Clo memory
T cells did not sustain expression of the other canonical Tfh cell
markers. Based on prior studies that demonstrated CXCR5+
memory CD4+ T cells could ‘‘help’’ secondary B cell responses
(Fazilleau et al., 2007; MacLeod et al., 2011), our data would sug-
gest that the PSGL1loLy6Clo (and possibly some PSGL1hiLy6Clo)
memory CD4+ T cells contain ‘‘rested down’’ Tfh memory cells,
but this requires further investigation.
Although most LCMV-specific CD4+ T cells developed into
Th1 cells that produced IFN-g, a substantial fraction (30%–
40%) of the cells did not produce IFN-g and this is consistent
with previous reports (Harrington et al., 2008; Johnston et al.,
2009). Furthermore, our analysis indicated they did not produce
substantial amounts of other signature effector T cell cytokines
(IL-17, IL-5, or IL-13) or express high amounts of FoxP3. This
observation suggests that some antiviral CD4+ T cells exist in
an uncommitted or less differentiated state, or alternatively,
perform functions that remain to be discovered. Moreover, it
was not surprising to find increased abundance of mRNAs for
the TFs Tbx21 and Eomes, the cytokines Ifng, Il18, and Il2, the
cytokine receptors IL2rb, IL12rb1, IL18r1, and IL18rap, and the
chemokine receptors Ccr5 and Cxcr3 in PSGL1hi memory
CD4+ T cells relative to naive CD4+ T cells given their Th1 cell
developmental bias. But an unexpected observation that
emerged was that the memory CD4+ T cells also contained
elevated amounts of mRNAs of other CD4+ Th cell lineage-deter-
mining TFs (Foxp3, c-maf, Rorc, Rora), cytokines (Il21, Il10, and
Il4), cytokine receptors (ILlr2, IL10ra, IL17rb, and IL17re), and
chemokine receptors (Ccr6, Ccr4, and Cxcr5) relative to naive
T cells. These data point to the possibility that memory CD4+
T cells exist in a polyfunctional poised state and may be respon-
sive to a multitude of cytokines that could influence their form
and function during subsequent infections. Perhaps memory
CD4+ T cells embody significant plasticity that permits inter-
conversion or transdifferentiation between functionally distinct
populations of CD4+ T cells as has been recently reported
(O’Shea and Paul, 2010). Further studies examining the plasticity
of antigen-specific Tfh and Th1 cell-containing memory CD4+
populations will determine whether their identities are stably644 Immunity 35, 633–646, October 28, 2011 ª2011 Elsevier Inc.maintained or whether conversion occurs between CD4+
memory subsets after reinfection. Understanding the molecular
mechanisms of memory CD4+ T cell generation, maintenance,
and plasticity will have biological implications for designing
therapeutic vaccination regimes against infections.
EXPERIMENTAL PROCEDURES
Mice and Infections
C57BL/6Ncr mice were purchased from the National Cancer Institute
(Frederick, MD). Stg chimeric mice were generated by adoptive transfer of
1 3 104 Thy1.1+ Stg CD4+ T cells into naive Thy1.2+ C57BL/6 mice and
rested for at least 1 day before infection. Tbx21/ mice were obtained from
L. Glimcher (Harvard Medical School, Cambridge, MA) and crossed to Stg
TCR transgenic mice. Mice were infected i.p. with 2 3 105 pfu LCMV
Armstrong or 2 3 106 pfu LCMV clone 13. All animal experiments were done
with approved Institutional Animal Care and Use Committee protocols.
Antibodies for Surface and Intracellular Staining
Lymphocyte isolation and surface and intracellular staining was performed as
described previously (Joshi et al., 2007). For in vitro stimulation, CD4+ T cells
were stimulated with the GP61-80 peptide (1 mg/ml) for 6 hr with Brefeldin A.
GP66-77 MHC class II tetramer (NIH tetramer core facility, Emory University,
Atlanta, GA) staining was performed as described (Johnston et al., 2009). Anti-
bodies were purchased from Ebioscience (San Diego, CA), BD PharMingen
(San Diego, CA), or BioLegend (San Diego, CA). Flow cytometry was acquired
on BD LSRII with Diva software and analyzed with Flow Jo software (Treestar,
San Carlos, CA).
Cell Isolation and Adoptive Transfers
Splenocytes were isolated from indicated days p.i. as previously described
(Joshi et al., 2007), enriched via negative selection or positive selection with
FlowComp mouse CD4+ Dynabeads (Invitrogen, Carlsbad, CA), stained with
requisite antibodies, and sorted with a FACSAria (BD Biosciences). Equal
numbers of Thy1.1+IL-7Rhi and Thy1.1+IL-7Rlo T cells or Thy1.1+PSGL1hi
Ly6Chi and Thy1.1+PSGL1hiLy6Clo T cells were transferred i.v. to either naive
or infection-matched (Thy1.2) recipient mice i.v. and analyzed at indicated
time points posttransfer. For recall experiments, mice were infected 1 or
30 days after adoptive transfer with 2 3 106 pfu LCMV clone 13.
Immunofluorescent Microscopy
On day 8 or day 30 after LCMV infection, spleens were isolated and embedded
in OCT compound (Sakura). Tissue blocks were frozen in isopentane
(Sigma-Aldrich) chilled by dry ice. Eight micrometer sections were cut with
a cryostat, air-dried, and fixed with cold acetone. Sections were stained
with 1–5 mg/ml mAb against B220, CD4, F4/80, PSGL1, Ly6C, Ly5.2, and/or
Thy1.1. The biotinylated Abs were visualized with Alexa 568-conjugated
streptavidin (Invitrogen). Images were captured on an Olympus BX-40 micro-
scope with a SPOT-RT Slider (Scanalytics) digital camera.
Gene Expression Profiling and qRT-PCR
DNAmicroarray analysis was performed on three independent samples of five
different Stg CD4+ T cell populations (purified to >95%purity on FACSAria [BD
Biosciences]): (1) naive, (2) day 8 PSGL1lo, (3) day 8 PSGL1hiLy6Chi, (4) day 8
PSGL1hiLy6Clo, and (5) day 60 PSGL1hi memory T cells. RNAwas isolated with
RNeasy kits (QIAGEN, Valencia, CA) and was hybridized toMouseRef-6 Bead-
Chips (Illumina, San Diego, CA) at the Yale KeckMicroarray Facility. Themicro-
array analysis was carried out with packages in R (R Development CoreTeam,
2010). Raw microarray data were normalized with the quantile method
provided by the lumi package. Differential gene expression was defined by
two criteria: (1) an absolute fold-changeR2 relative to naive samples and (2)
a statistically significant change in expression as determined by LIMMA with
a Benjamani-Hochberg false discovery rate cutoff q < 0.05. Heatmaps were
generated with a fold-change R 32 and q < 0.0001. Hierarchical clustering
was based on Euclidean distance metric and Ward’s linkage. In addition, the
microarray data were also analyzed with GeneSpring GX 11.5.1 (Agilent Tech-
nologies) with quantile normalization. Gene lists for Table 1 and Tables S1 and
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Antiviral Memory CD4+ T Cell DevelopmentS2 were generated on the basis of fold changes from this analysis along with
consideration of biological relevance.
qRT-PCR was performed as previously described (Chandele et al., 2008)
and values were normalized to the ribosomal protein L9. Primers used were
as follows: L9: 50-TGAAGAAATCTGTGGGTCG-30 (forward), 50-GCACTACGG
ACATAGGAACT-30 (reverse); Tbx21: 50-CAACAACCCCT TTGCCAAAG-30
(forward), 50-TCCCCCAA GCAGTTGACAGT-30 (reverse); Bcl6: 50-CTGCAG
ATGGAGCATGTTGT-30 (forward), 50-CACCCGGGAGTATTTCTCAG-30.
Statistical Analysis
Where indicated, p values were determined by two-tailed unpaired Student’s
t test. p values < 0.05 were considered significant. All error bars represent
standard deviation.
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Themicroarray data are available in theGene ExpressionOmnibus (GEO) data-
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